BioCentury
ARTICLE | Company News

Management tracks: Zafgen, Rigel

May 30, 2018 8:45 PM UTC

Metabolic disease company Zafgen Inc. (NASDAQ:ZFGN) hired Brian McVeigh as CBO. He was VP of worldwide business development transactions and investment management at GlaxoSmithKline plc (LSE:GSK; NYSE:GSK).

Immunology and cancer company Rigel Pharmaceuticals Inc. (NASDAQ:RIGL) hired Dean Schorno as EVP and CFO. He was CFO and head of operations at 23andMe Inc. (Mountain View, Calif.)...